101
|
Steinhart MR, van der Valk WH, Osorio D, Serdy SA, Zhang J, Nist-Lund C, Kim J, Moncada-Reid C, Sun L, Lee J, Koehler KR. Mapping oto-pharyngeal development in a human inner ear organoid model. Development 2023; 150:dev201871. [PMID: 37796037 PMCID: PMC10698753 DOI: 10.1242/dev.201871] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Accepted: 09/08/2023] [Indexed: 10/06/2023]
Abstract
Inner ear development requires the coordination of cell types from distinct epithelial, mesenchymal and neuronal lineages. Although we have learned much from animal models, many details about human inner ear development remain elusive. We recently developed an in vitro model of human inner ear organogenesis using pluripotent stem cells in a 3D culture, fostering the growth of a sensorineural circuit, including hair cells and neurons. Despite previously characterizing some cell types, many remain undefined. This study aimed to chart the in vitro development timeline of the inner ear organoid to understand the mechanisms at play. Using single-cell RNA sequencing at ten stages during the first 36 days of differentiation, we tracked the evolution from pluripotency to various ear cell types after exposure to specific signaling modulators. Our findings showcase gene expression that influences differentiation, identifying a plethora of ectodermal and mesenchymal cell types. We also discern aspects of the organoid model consistent with in vivo development, while highlighting potential discrepancies. Our study establishes the Inner Ear Organoid Developmental Atlas (IODA), offering deeper insights into human biology and improving inner ear tissue differentiation.
Collapse
Affiliation(s)
- Matthew R. Steinhart
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Wouter H. van der Valk
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA
- OtoBiology Leiden, Department of Otorhinolaryngology and Head & Neck Surgery; Leiden University Medical Center, Leiden 2333 ZA, the Netherlands
- The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW); Leiden University Medical Center, Leiden, 2333 ZA, the Netherlands
| | - Daniel Osorio
- Research Computing, Department of Information Technology; Boston Children's Hospital, Boston, MA 02115, USA
| | - Sara A. Serdy
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
| | - Jingyuan Zhang
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA
| | - Carl Nist-Lund
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA
| | - Jin Kim
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA
- Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA 02115, USA
| | - Cynthia Moncada-Reid
- Speech and Hearing Bioscience and Technology (SHBT) Graduate Program, Harvard Medical School, Boston, MA 02115, USA
| | - Liang Sun
- Research Computing, Department of Information Technology; Boston Children's Hospital, Boston, MA 02115, USA
| | - Jiyoon Lee
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA
- Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA 02115, USA
| | - Karl R. Koehler
- Department of Otolaryngology, Boston Children's Hospital, Boston, MA 02115, USA
- F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA
- Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA 02115, USA
| |
Collapse
|
102
|
Chari T, Gorin G, Pachter L. Biophysically Interpretable Inference of Cell Types from Multimodal Sequencing Data. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.09.17.558131. [PMID: 37745403 PMCID: PMC10516047 DOI: 10.1101/2023.09.17.558131] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/26/2023]
Abstract
Multimodal, single-cell genomics technologies enable simultaneous capture of multiple facets of DNA and RNA processing in the cell. This creates opportunities for transcriptome-wide, mechanistic studies of cellular processing in heterogeneous cell types, with applications ranging from inferring kinetic differences between cells, to the role of stochasticity in driving heterogeneity. However, current methods for determining cell types or 'clusters' present in multimodal data often rely on ad hoc or independent treatment of modalities, and assumptions ignoring inherent properties of the count data. To enable interpretable and consistent cell cluster determination from multimodal data, we present meK-Means (mechanistic K-Means) which integrates modalities and learns underlying, shared biophysical states through a unifying model of transcription. In particular, we demonstrate how meK-Means can be used to cluster cells from unspliced and spliced mRNA count modalities. By utilizing the causal, physical relationships underlying these modalities, we identify shared transcriptional kinetics across cells, which induce the observed gene expression profiles, and provide an alternative definition for 'clusters' through the governing parameters of cellular processes.
Collapse
Affiliation(s)
- Tara Chari
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California
| | - Gennady Gorin
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California
| | - Lior Pachter
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California
- Department of Computing and Mathematical Sciences, California Institute of Technology, Pasadena, California
| |
Collapse
|
103
|
David KT, Halanych KM. Unsupervised Deep Learning Can Identify Protein Functional Groups from Unaligned Sequences. Genome Biol Evol 2023; 15:evad084. [PMID: 37217837 PMCID: PMC10231473 DOI: 10.1093/gbe/evad084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2023] [Revised: 05/11/2023] [Accepted: 05/18/2023] [Indexed: 05/24/2023] Open
Abstract
Interpreting protein function from sequence data is a fundamental goal of bioinformatics. However, our current understanding of protein diversity is bottlenecked by the fact that most proteins have only been functionally validated in model organisms, limiting our understanding of how function varies with gene sequence diversity. Thus, accuracy of inferences in clades without model representatives is questionable. Unsupervised learning may help to ameliorate this bias by identifying highly complex patterns and structure from large datasets without external labels. Here we present DeepSeqProt, an unsupervised deep learning program for exploring large protein sequence datasets. DeepSeqProt is a clustering tool capable of distinguishing between broad classes of proteins while learning local and global structure of functional space. DeepSeqProt is capable of learning salient biological features from unaligned, unannotated sequences. DeepSeqProt is more likely to capture complete protein families and statistically significant shared ontologies within proteomes than other clustering methods. We hope this framework will prove of use to researchers and provide a preliminary step in further developing unsupervised deep learning in molecular biology.
Collapse
Affiliation(s)
- Kyle T David
- Department of Biological Sciences, Auburn University, Auburn, Alabama, USA
| | - Kenneth M Halanych
- Center for Marine Sciences, University of North Carolina Wilmington, Wilmington, North Carolina, USA
| |
Collapse
|
104
|
Király B, Hangya B. Navigating the Statistical Minefield of Model Selection and Clustering in Neuroscience. eNeuro 2022; 9:ENEURO.0066-22.2022. [PMID: 35835556 PMCID: PMC9282170 DOI: 10.1523/eneuro.0066-22.2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Revised: 06/16/2022] [Accepted: 06/22/2022] [Indexed: 11/21/2022] Open
Abstract
Model selection is often implicit: when performing an ANOVA, one assumes that the normal distribution is a good model of the data; fitting a tuning curve implies that an additive and a multiplicative scaler describes the behavior of the neuron; even calculating an average implicitly assumes that the data were sampled from a distribution that has a finite first statistical moment: the mean. Model selection may be explicit, when the aim is to test whether one model provides a better description of the data than a competing one. As a special case, clustering algorithms identify groups with similar properties within the data. They are widely used from spike sorting to cell type identification to gene expression analysis. We discuss model selection and clustering techniques from a statistician's point of view, revealing the assumptions behind, and the logic that governs the various approaches. We also showcase important neuroscience applications and provide suggestions how neuroscientists could put model selection algorithms to best use as well as what mistakes should be avoided.
Collapse
Affiliation(s)
- Bálint Király
- Lendület Laboratory of Systems Neuroscience, Institute of Experimental Medicine, H-1083, Budapest, Hungary
- Department of Biological Physics, Eötvös Loránd University, H-1083, Budapest, Hungary
| | - Balázs Hangya
- Lendület Laboratory of Systems Neuroscience, Institute of Experimental Medicine, H-1083, Budapest, Hungary
| |
Collapse
|